Illinois 2023-2024 Regular Session

Illinois Senate Bill SB3780

Introduced
2/9/24  

Caption

MEDICAID-NONOPIOID MEDS

Impact

If passed, SB3780 would create significant changes in coverage policies within Illinois Medicaid, ensuring that FDA-approved nonopioid pain medications do not face disadvantages or excessive regulations compared to opioid medications. The Department of Healthcare and Family Services will be required to adjust the Illinois Medicaid Preferred Drug List to reflect this new parity in coverage, thus promoting the use of nonopioid options for pain relief. It ensures that nonopioid medications will not be classified as non-preferred simply because an opioid is available as a preferred option, thereby facilitating access to various treatment options for patients.

Summary

SB3780, introduced by Senator Karina Villa, seeks to amend the Medical Assistance Article of the Illinois Public Aid Code by ensuring that nonopioid medications prescribed for the treatment of acute pain receive equal coverage under Medicaid. Specifically, the bill prohibits either the Department of Healthcare and Family Services or any managed care organization contracted to deny coverage for nonopioid medications in favor of opioids, as well as disallowing requirements for patients to first try opioids before accessing nonopioid options. This initiative aligns with ongoing efforts to combat the opioid crisis by encouraging alternatives to opioid prescriptions for pain management.

Contention

As with any legislative proposal, SB3780 may encounter debate centered on the implications of altering medication coverage under Medicaid. Proponents of the bill argue that removing barriers to nonopioid medications will not only provide greater freedom of choice for healthcare providers and patients but also serve as a proactive step against the dependence and addiction that can arise from opioid use. However, there could be opposition from segments of the healthcare community concerned about the financial impacts on managed care organizations and potential complications in managing patients' pain effectively if nonopioid medications are used preferentially.

Companion Bills

No companion bills found.

Previously Filed As

IL SB161

Medicaid; establishing coverage parity between opioid and nonopioid pain medications.

IL SB1238

NONOPIOID ALTERNATIVES

IL HB2852

NONOPIOID ALTERNATIVES ACT

IL SB128

AN ACT relating to utilization controls for nonopioid analgesics in the Medicaid program.

IL SB2388

Medicaid; create provisions effecting parity in the prescription of pain medication.

IL SB56

AN ACT relating to utilization controls for nonopioid analgesics in the Medicaid program.

IL SSB1169

A bill for an act relating to nonopioid drugs on the medical assistance preferred drug list, and health carriers' development of a pain management access plan.

IL HSB151

A bill for an act relating to nonopioid drugs on the medical assistance preferred drug list, and health carriers' development of a pain management access plan.

IL SB2025

Medicaid and health insurance insurers; create provisions effecting parity in the prescription of pain medication.

IL HB1389

Nonopioid drugs for pain management; require health plans and Medicaid to cover and not make use of more restrictive than for opioid drugs.

Similar Bills

NJ A1821

Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

NJ S4283

Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

IL SB1238

NONOPIOID ALTERNATIVES

IL HB2852

NONOPIOID ALTERNATIVES ACT

WV SB628

Relating to non-opioid medication

WV SB248

Increasing availability of prescription non-opioid medications

KS HB2364

Prohibiting certain health insurers from requiring cost-sharing for nonopioid prescription drugs or providing less favorable coverage for such drug than that for opioid or narcotic prescription drugs for the treatment of pain.

OR SB598

Relating to step therapy for nonopioids.